Clarius Group’s Karuna Therapeutics KRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding KRTX
Clarius Group's KRTX Position: Q1 2024 in Review
Clarius Group sold out of Karuna Therapeutics (KRTX) in Q1 2024, closing a stake of 69,248 shares — an estimated $21.9M sold.
Clarius Group first reported a position in KRTX in Q2 2022 and held it in 7 quarters. The position peaked at $24.7M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- Clarius Group reported no remaining Karuna Therapeutics position as of Q1 2024 after selling out during the quarter.
- Clarius Group sold 69,248 Karuna Therapeutics shares in Q1 2024, an estimated $21.9M.
- Clarius Group first reported a position in Karuna Therapeutics in Q2 2022 and held it in 7 quarters.
- Clarius Group's Karuna Therapeutics position peaked at $24.7M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics as of Q1 2024.
Based on Clarius Group's 13F filing for Q1 2024, filed 17 Apr 2024.